Study type
Diabetes studies recruiting now
Diabetes research covers type 1 and type 2 diabetes, prediabetes and related complications, testing medicines, devices such as glucose monitors and insulin pumps, and lifestyle programs.
362 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Tucson, AZ + 39 other US sites
- Eligibility basics
- Ages 10–17
- Recruiting
Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers
Omeza, LLC
- Location
- Evergreen Park, IL + 9 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Well Cell Global
- Location
- Phoenix, AZ + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
AstraZeneca
- Location
- Ocoee, FL
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Walden Biosciences
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Insulet Corporation
- Location
- Los Angeles, CA + 25 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Insulet Corporation
- Location
- Los Angeles, CA + 10 other US sites
- Eligibility basics
- Ages 14–75
- RecruitingPhase 2
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Gateway Institute for Brain Research
- Location
- Davie, FL + 3 other US sites
- Eligibility basics
- Ages 30+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Birmingham, AL + 69 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company
- Location
- Birmingham, AL + 35 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Neurologic Stem Cell Treatment Study
MD Stem Cells
- Location
- Westport, CT + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Pharming Technologies B.V.
- Location
- Orange, CA + 10 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity
RxFunction Inc.
- Location
- Jacksonville, FL
- Eligibility basics
- Ages 60+
- Recruiting
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
NuScience Medical Biologics, LLC
- Location
- Alexandria, LA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
Sequence LifeScience, Inc.
- Location
- Monroeville, PA
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
Hua Medicine Limited
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Zucara Therapeutics Inc.
- Location
- Birmingham, AL + 36 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
Portal Diabetes, Inc.
- Location
- Chula Vista, CA
- Eligibility basics
- Ages 18–60
- RecruitingPhase 2
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Housey Healthcare ULC
- Location
- Canoga Park, CA + 24 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
Senseonics, Inc.
- Location
- Escondido, CA
- Eligibility basics
- Ages 18+
- Recruiting
ROME GS System Study
Senseonics, Inc.
- Location
- Escondido, CA + 2 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
i-SENS, Inc.
- Location
- Walnut Creek, CA + 1 other US site
- Eligibility basics
- Ages 18–65
- Recruiting
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
Surgenex
- Location
- Vista, CA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Op-T LLC
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Ages 18–50
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Will I have to stop my diabetes medicine?
Some studies change or pause medicines under close supervision; many add a study treatment on top of your current care. Never change medicines on your own; the study team and your doctor decide this together.